Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/27/2012EP2467366A1 Novel fxr (nr1h4 ) binding and activity modulating compounds
06/27/2012EP2467362A2 Phosphatidylcholine transfer protein inhibitors
06/27/2012EP2467361A1 Novel quinoline-hepcidine antagonists
06/27/2012EP2467359A2 (bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
06/27/2012EP2467358A2 Novel complex for treatment and/or prophylaxis of parasitic infections
06/27/2012EP2467167A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
06/27/2012EP2467146A1 Preventing and curing beneficial insect diseases via plant transcribed molecules
06/27/2012EP2467145A1 Compositions containing mixtures of fermentable fibers
06/27/2012EP2467144A1 Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis
06/27/2012EP2467143A1 Broad spectrum preservation blends
06/27/2012EP2467142A2 Heat shock protein binding compounds, compositions, and methods for making and using same
06/27/2012EP2467141A1 Heterocyclic compounds and uses thereof
06/27/2012EP2467140A2 Method of threating cancer
06/27/2012EP2467139A1 Imatinib immunoassay
06/27/2012EP2467138A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease
06/27/2012EP2467137A1 Biaryl compounds and methods of use thereof
06/27/2012EP2467136A1 4-methylpyrazole formulations
06/27/2012EP2467135A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders
06/27/2012EP2467134A1 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof
06/27/2012EP2467131A2 Controlled-release formulations of anabaseine compounds and uses thereof
06/27/2012EP2467129A1 The granules with improved solubility and stability
06/27/2012EP2467128A1 Use of glyceryl trinitrate for treating traumatic edema
06/27/2012EP2467127A1 Topical gels
06/27/2012EP2467126A1 Drug delivery systems (wafer) for pediatric use
06/27/2012EP2467033A2 Regulating the amino acid pool used for the acute-phase protein synthesis
06/27/2012EP2467018A1 Phytoceutical compositions for pets
06/27/2012EP2424523B1 Sublingual spray formulation comprising dihydroartemesinin
06/27/2012EP2326328B1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity
06/27/2012EP2311459B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
06/27/2012EP2235021B1 Epoxy-guaiane derivatives and treatment of cancer
06/27/2012EP2225253B1 Phosphonic acid derivates and their use as p2y12 receptor antagonists
06/27/2012EP2225252B1 C2-c5-alkyl-imidazole-bisphosphonates
06/27/2012EP2222166B1 Heterocyclic kinase inhibitors
06/27/2012EP2215089B1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
06/27/2012EP2202216B1 Spiro-ring compound and use thereof for medical purposes
06/27/2012EP2188263B1 Benzimidazole derivatives used as fxr agonists
06/27/2012EP2185553B1 Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/27/2012EP2150251B1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
06/27/2012EP2125735B1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/27/2012EP2124924B1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases
06/27/2012EP2123628B1 A process for preparing optical pure milnacipran and its pharmaceutically accepted salts
06/27/2012EP2120873B1 Topical dosage form comprising tri-substituted glycerol compounds
06/27/2012EP2117521B1 Transdermal delivery systems comprising bupivacaine
06/27/2012EP2114980B1 Antiviral nucleoside analogs
06/27/2012EP2111409B1 Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent
06/27/2012EP2097079B1 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/27/2012EP2074096B1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
06/27/2012EP2062581B1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents
06/27/2012EP2023939B1 Compounds and methods for modulating expression of pcsk9
06/27/2012EP2013170B1 4-squarylpiperazine derivatives as antiviral agents
06/27/2012EP2009992B1 Il-8 receptor antagonists
06/27/2012EP2007765B1 Immunopotentiating compounds
06/27/2012EP2007755B1 Fused ring thrombin receptor antagonists
06/27/2012EP2007729B1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
06/27/2012EP1999120B1 Benzothiazoles having histamine h3 receptor activity
06/27/2012EP1991559B1 Oxa-steroids derivatives as selective progesterone receptor modulators
06/27/2012EP1989217B1 11-phosphorous steroid derivatives useful as progesterone receptor modulators
06/27/2012EP1985296B1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
06/27/2012EP1984340B1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
06/27/2012EP1949902B1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR
06/27/2012EP1919921B1 Bicyclic heterocycles as hiv integrase inhibitors
06/27/2012EP1919487B1 Particulate compositions comprising alginate and/or alginic acid
06/27/2012EP1868600B1 Spirocyclic cyclohexane derivatives for use in the treatment of substance dependency
06/27/2012EP1856042B1 Substituted gamma lactams as therapeutic agents
06/27/2012EP1800681B1 Solid pharmaceutical composition comprising the thiazolyl methyl ester of [5s-(5r*,8r*,10r*,11r*)]-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-1(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid and preparation method thereof
06/27/2012EP1775292B1 Salts of benzimidazole derivative with amines and process for production thereof
06/27/2012EP1771548B1 Use of dendrimers to stimulate cell growth
06/27/2012EP1751087B1 Levodopa derivatives, and compositions and uses thereof
06/27/2012EP1734946B1 Punicic acid for use to enhance immune response and treating inflammatory bowel disease
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012EP1697352B1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
06/27/2012EP1692187B1 EC SOD and cell transducing EC SOD and use thereof
06/27/2012EP1670449B1 Thyroid hormone analogs and methods of use in angiogenesis
06/27/2012EP1636190B1 Stable crystal of 4-oxoquinoline compound
06/27/2012EP1626958B1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists
06/27/2012EP1587480B1 Polyhydroxylated pyrrolizidine
06/27/2012EP1562909B1 Ophthalmic compositions for treating ocular hypertension
06/27/2012EP1549313B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN1995041B Pyridazineindole derivative and its use
06/27/2012CN1972919B Method for producing 4-(benzimidazolylmethylamino)-benzamidines
06/27/2012CN1972688B 4-phenylamino-quinazolin-6-yl-amides
06/27/2012CN1903243B Guhong control-release tablets and prepn. method therefor
06/27/2012CN1882587B Use of tricyclic compounds as glycine transport inhibitors
06/27/2012CN1869050B Method of preparing notoginseng saponine Fe and diol group ginseng saponine from netoginseng leaf
06/27/2012CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
06/27/2012CN1816524B Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/27/2012CN1724519B Indole kind compound with insuline sensitizing activity and its preparation method and use
06/27/2012CN1678304B PKC activation as a means for enhancing aAPP-a secretion and improving cognition using bryostatin type compounds
06/27/2012CN1665828B Novel substituted sulfamate anticonvulsant derivatives
06/27/2012CN1615155B Anti-proliferative composition
06/27/2012CN102520081A Detection method for traditional Chinese preparation capable of activating blood circulation to dissipate blood stasis
06/27/2012CN102517354A Preparation method of water-soluble active polysaccharide in boletus edulis, and application thereof
06/27/2012CN102517292A Immunostimulatory oligoribonucleotides
06/27/2012CN102516533A Block copolymer for drug conjugates and their pharmaceutical compositions
06/27/2012CN102516417A Cyclodextrin-based polymers for therapeutics delivery
06/27/2012CN102516404A Preparation method of rosuvastatin-dextran ester
06/27/2012CN102516388A Anthropogenic LMP1 (latent membrane protein1) extracellular regional antibody for nasopharyngeal carcinoma and application thereof
06/27/2012CN102516385A Nerve growth factor-paclitaxel conjugate, manufacturing method and uses thereof
1 ... 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 ... 7860